A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Clinical Activity of EQ001 in Subjects with Moderate-To-Severe Uncontrolled Asthma
- Bardin, Philip (Primary Chief Investigator (PCI))
Project: Research